Nayomi Omura is a Dermatology physician. OpenAlex indexes 12 publications with 398 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2601 S Kanner Hwy
Stuart, FL 349944622
Telephone
772-219-2777Provider last certified this registry record 5 Jan 2021.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202510 payments
- Regeneron Healthcare Solutions, Inc.Program year20258 payments
- ABBVIE INC.Program year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
36%Corticosteroid16.1%Triamcinolone Acetonide86%Triamcinolone acetonide14%Part D + Part B≥202 patientsPolyene Antifungal7.3%Nystatin92%Nystop8%Part D<11 patients+ 7 more classes in this area
Anti-infectives
22.5%Tetracycline-class Drug5.9%Doxycycline Hyclate100%Part D≥57 patientsAzole Antifungal5.4%Ketoconazole80%Fluconazole20%Part D≥57 patients+ 4 more classes in this area
Cancer & immunology
16%Nucleoside Metabolic Inhibitor10.6%Fluorouracil100%Part D≥172 patientsPorphyrin Precursor1.1%Aminolevulinic acid hcl100%Part B, office-administered≥14 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment of reticular leg veins with a 1064 nm long-pulsed Nd:YAG laser
Journal of the American Academy of Dermatology
2003 - Clinically Significant Facial Edema After Extensive Treatment With Purpura-Free Pulsed-Dye Laser
Dermatologic Surgery
2003 - Clinically Significant Facial Edema After Extensive Treatment With Purpura-Free Pulsed-Dye Laser
Dermatologic Surgery
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”